期刊文献+

胺碘酮治疗急性冠状动脉综合征并发快速心房颤动的疗效观察

Effects of treatment for acute coronary syndrome with fast atrial fibrillation with amiodarone
下载PDF
导出
摘要 目的:观察静脉应用胺碘酮治疗急性冠状动脉综合征(ACS)并发快速心房颤动(AF)的临床疗效及安全性。方法:对48例ACS伴新近发生快速AF的患者,先静脉注射胺碘酮150 mg,随后以0.5~1.0 mg/min静脉滴注维持0.5~24 h,观察治疗后30 min、2 h、24 h时AF转复、心室率控制、血压变化、心功能与复律情况及药物不良反应。结果:用药后36例AF转复为窦性心律,转复率75.0%;用药后心室率明显下降,与治疗前差异均有统计学意义(P<0.01);治疗前后收缩压变化不明显(P>0.05),但用药后不同时间的舒张压均低于用药前(P<0.01)。心功能Ⅰ、Ⅱ级的ACS患者复律率(82.9%)高于心功能Ⅲ、Ⅳ级组复律率(46.2%)(P<0.05)。出现窦性心动过缓5例(10.4%),减量或停药后恢复正常;血压偏低4例(8.3%),予多巴胺升压后恢复正常。结论:静脉注射胺碘酮对ACS并发快速AF转复率较高,不良反应较少。 Objective.To observe the effects and safety of intravenous injection amiodarone on acute coronary syndrome(ACS) with fast atrial fibrillation(AF). Methods:Forty-eight cases with ACS with fast AF were treated with intravenous injection of amiodarone, and maintained at 0.5 - 1.0 mg/min for 0. 5 - 24 hours. The reversion of AF, the ventrieular rates, blood pressure and side-effects were observed at 30 min ,2 hour and 24 hour after treatment. Results:Compared with pretreatment,36 cases were reverted( the reversion rates as 75% ) and the ventricular rates were apparent decline after treatment( P 〈 0.01 ). Systolic blood pressure change was not apparent, but the diastolic blood pressure after treatment was lower than that of pre-treatment(P 〈0.05 ) ,The reversion rates of cardiac function with grade Ⅰ and Ⅱ (82.'9%) were higher than that of cardiac function with grade Ⅲ and Ⅳ (46.2%)( P 〈 0.05 ). Five cases( 10. 4% ) with sinus bradycardia and 4 eases (8.3 % ) with low blood pressure after reduction or stopping the drug, which could recover after giving dopamine were observed. Conclusions : Treatment of ACS with fast AF with intravenous injection of amiodarone have higher reversion rates and fewer side-effects.
作者 戴志江
出处 《蚌埠医学院学报》 CAS 2012年第8期939-940,943,共3页 Journal of Bengbu Medical College
关键词 急性冠状动脉综合征 心肌缺血 心房颤动 胺碘酮 acute coronary syndrome myocardial ischemia atrial fibrillation amiodarone
  • 相关文献

参考文献9

  • 1Cameron A, Schwartz M J, Kronmal RA, et al. Prevalence and significance of atrial fibrillation in coronary artery disease ( CASS Registry) [ J]. Am J Cardiol, 1988,61 (10) :714 -717.
  • 2Lopes RD, Pieper KS, Horton JR, et al. Short-and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation[ J]. Heart,2008, 94(7) :867 -873.
  • 3Lan DH, Huynh LT, Chew DP,et al. Prognostic impact of types of atrial fibrillatin in acute coronary syndromes [ J ]. Am J Cardiol, 2009,104(10) :1317 - 1323.
  • 4张新,华伟.心房颤动的药物治疗[J].中国综合临床,2005,21(10):952-955. 被引量:5
  • 5蒋文平.胺碘酮抗心律失常治疗应用指南(2008)[J].中国心脏起搏与心电生理杂志,2008,22(5):377-385. 被引量:144
  • 6沈志坚.胺碘酮治疗快速性心律失常的临床效果研究[J].中国医药指南,2010,8(20):26-27. 被引量:5
  • 7郭继鸿.胺碘酮的药代学与作用(一)[J].中华临床医师杂志(电子版),2007,1(2):71-77. 被引量:7
  • 8Cybulski J, Kulakowski P, Budaj A, et al. Intravenous amiodarone for eardioversion of recent-onset a trial fibrillation [ J ]. Clin Cardiol,2003,2(7 ) :329 - 335.
  • 9Fuster V, Rydn LE, Cannom DS, et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation : a report of the American College of Cardiology Foundatiow/American Heart Association Task Force on practice guidelines [ J ]. Circulation ,2011,123 (10) : e269 - e367.

二级参考文献38

共引文献157

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部